ImClone talks with U.S. on cancer drug
ImClone Systems Inc. and Bristol-Myers Squibb Co. have met with the U.S Food and Drug Administration about the prospects for ImClone's cancer drug in what is believed to be the first direct meeting
ImClone Systems Inc. and Bristol-Myers Squibb Co. have met with the U.S Food and Drug Administration about the prospects for ImClone's cancer drug in what is believed to be the first direct meeting